Cargando…
Direct evidence on the efficacy of GnRH agonist in recurrent steroid cell tumor-not otherwise specified
BACKGROUND: Steroid cell tumor (SCT) not otherwise specified (NOS) is rare and recurrence and metastasis rarely occurs; therefore, reports regarding its treatment are limited. We report a case of recurrent SCT-NOS treated with gonadotropin releasing hormone agonist (GnRHa) and successful. CASE: A 50...
Autores principales: | Nakasone, Tadaharu, Nakamoto, Tomoko, Matsuzaki, Akiko, Nakagami, Hiroshige, Aoki, Yoichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660559/ https://www.ncbi.nlm.nih.gov/pubmed/31372485 http://dx.doi.org/10.1016/j.gore.2019.07.006 |
Ejemplares similares
-
Comparison of GnRH Agonist, GnRH Antagonist, and GnRH Antagonist Mild Protocol of Controlled Ovarian Hyperstimulation in Good Prognosis Patients
por: Stimpfel, Martin, et al.
Publicado: (2015) -
GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
por: Cota, Ana Marcia M, et al.
Publicado: (2012) -
Comparison of long GnRH agonist versus GnRH antagonist protocol in poor responders
por: Şahin, Sadık, et al.
Publicado: (2014) -
Microdose GnRH Agonist Flare-Up versus Ultrashort GnRH Agonist
Combined with Fixed GnRH Antagonist in Poor Responders of
Assisted Reproductive Techniques Cycles
por: Eftekhar, Maryam, et al.
Publicado: (2013) -
GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET)
por: Depalo, Raffaella, et al.
Publicado: (2012)